Patents by Inventor Craig R. Travis

Craig R. Travis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Non-hormonal treatment of the genitourinary syndrome of menopause
    Patent number: 11033527
    Abstract: Methods of treating the genitourinary syndrome of menopause (GSM) and modulating expression of genes involved in the GSM in an individual include administering compound L759,633 or compound JWH-133, both selective ligands for the endocannabinoid receptor type 2 (CB2). These compounds and compositions containing these compounds can be used as a non-hormonal alternative to hormones such as estrogen and ospemiphene for the treatment of the GSM and in particular, vaginal atrophy (VVA).
    Type: Grant
    Filed: February 7, 2019
    Date of Patent: June 15, 2021
    Assignee: IMMUGEN PHARMA LLC
    Inventor: Craig R. Travis
  • NON-HORMONAL TREATMENT OF THE GENITOURINARY SYNDROME OF MENOPAUSE
    Publication number: 20190240190
    Abstract: Methods of treating the genitourinary syndrome of menopause (GSM) and modulating expression of genes involved in the GSM in an individual include administering compound L759,633 or compound JWH-133, both selective ligands for the endocannabinoid receptor type 2 (CB2). These compounds and compositions containing these compounds can be used as a non-hormonal alternative to hormones such as estrogen and ospemiphene for the treatment of the GSM and in particular, vaginal atrophy (VVA).
    Type: Application
    Filed: February 7, 2019
    Publication date: August 8, 2019
    Applicant: IMMUGEN PHARMA LLC
    Inventor: Craig R. Travis
  • Cannabinol derivatives
    Patent number: 7105685
    Abstract: The invention provides cannabinol derivatives and pharmaceutical preparations thereof.
    Type: Grant
    Filed: December 22, 2002
    Date of Patent: September 12, 2006
    Inventor: Craig R. Travis
  • Antiviral methods and compounds
    Publication number: 20040242870
    Abstract: The invention provides a method, compounds, and compositions for inhibiting the replication or proliferation of a virus. In accordance with the invention, at least one cannabichromene derivative is exposed to the virus, a host cell, or an infected cell under conditions sufficient to inhibit the replication or proliferation of the virus.
    Type: Application
    Filed: April 5, 2004
    Publication date: December 2, 2004
    Applicant: Immugen Pharmaceuticals, Inc.
    Inventor: Craig R. Travis
  • Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
    Publication number: 20040138315
    Abstract: The invention provides a method for attenuating the aggregation and/or activation of blood platelets within a blood product. In accordance with this method, a cannabinoid or resorcinolic compound is introduced into the blood product under conditions sufficient to inhibit the aggregation and/or activation of blood platelets within the blood product. The invention also pertains to the use of a cannabinoid or resorcinolic compound to prepare a composition suitable for inhibiting the activation and/or aggregation of blood platelets and to such compositions. The invention also pertains to a method of selectively inhibiting COX-1 and thromboxane synthase within a cell or blood platelet.
    Type: Application
    Filed: December 16, 2003
    Publication date: July 15, 2004
    Applicant: Immugen Pharmaceuticals, Inc.
    Inventor: Craig R. Travis
  • Topical formulations of resorcinols and cannibinoids and methods of use
    Publication number: 20030232101
    Abstract: In one aspect, the invention provides a method for preventing the transmission of HIV from one individual to another. In accordance with the method, a pharmacologically-acceptable composition including at least one resorcinol derivative compound and/or cannabinoid (e.g., cannabinol derivatives, &Dgr;8-THC derivatives, cannabichromene derivatives, cannabidiol derivatives, cannabigerol derivatives) (including combinations thereof) is administered topically to a first individual harboring HIV, or to a second individual at risk of infection with HIV, proximate in time with contact between the first individual and the second individual. The invention also provides topical formulations of at least one resorcinol and/or cannabinoid and water insoluble polymers as hydrogels.
    Type: Application
    Filed: March 18, 2003
    Publication date: December 18, 2003
    Applicant: Immugen Pharmaceuticals, Inc.
    Inventor: Craig R. Travis
  • Antiviral methods and compounds
    Publication number: 20030171372
    Abstract: The invention provides a method, compounds, and compositions for inhibiting the replication or proliferation of a virus. In accordance with the invention, at least one cannabichromene derivative is exposed to the virus, a host cell, or an infected cell under conditions sufficient to inhibit the replication or proliferation of the virus.
    Type: Application
    Filed: January 16, 2003
    Publication date: September 11, 2003
    Applicant: Immugen Pharmaceuticals, Inc.
    Inventor: Craig R. Travis
  • Cannabinol derivatives
    Publication number: 20030158191
    Abstract: The invention provides cannabinol derivatives and pharmaceutical preparations thereof.
    Type: Application
    Filed: December 22, 2002
    Publication date: August 21, 2003
    Inventor: Craig R. Travis
  • Resorcinolic compounds
    Patent number: 6566560
    Abstract: The invention provides a resorcinol derivative and a method of using the resorcinol derivative to attenuate the growth of a neoplasm.
    Type: Grant
    Filed: August 13, 2001
    Date of Patent: May 20, 2003
    Assignee: Immugen Pharmaceuticals, Inc.
    Inventor: Craig R. Travis
  • Antiviral methods and compounds
    Patent number: 6541510
    Abstract: The invention provides a method, compounds, and compositions for inhibiting the replication or proliferation of a virus. In accordance with the invention, at least one cannabichromene derivative is exposed to the virus, a host cell, or an infected cell under conditions sufficient to inhibit the replication or proliferation of the virus.
    Type: Grant
    Filed: September 28, 2001
    Date of Patent: April 1, 2003
    Assignee: Immugen Pharmaceuticals, Inc.
    Inventor: Craig R. Travis
  • Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
    Publication number: 20020137802
    Abstract: The invention provides a method for attenuating the aggregation and/or activation of blood platelets within a blood product. In accordance with this method, a cannabinoid or resorcinolic compound is introduced into the blood product under conditions sufficient to inhibit the aggregation and/or activation of blood platelets within the blood product. The invention also pertains to the use of a cannabinoid or resorcinolic compound to prepare a composition suitable for inhibiting the activation and/or aggregation of blood platelets and to such compositions. The invention also pertains to a method of selectively inhibiting COX-1 and thromboxane synthase within a cell or blood platelet.
    Type: Application
    Filed: September 28, 2001
    Publication date: September 26, 2002
    Inventor: Craig R. Travis
  • Antiviral methods and compounds
    Publication number: 20020068738
    Abstract: The invention provides a method, compounds, and compositions for inhibiting the replication or proliferation of a virus. In accordance with the invention, at least one cannabichromene derivative is exposed to the virus, a host cell, or an infected cell under conditions sufficient to inhibit the replication or proliferation of the virus.
    Type: Application
    Filed: September 28, 2001
    Publication date: June 6, 2002
    Inventor: Craig R. Travis
  • Resorcinolic compounds
    Publication number: 20020037923
    Abstract: The invention provides a resorcinol derivative and a method of using the resorcinol derivative to attenuate the growth of a neoplasm.
    Type: Application
    Filed: August 13, 2001
    Publication date: March 28, 2002
    Inventor: Craig R. Travis